Ondřej Soukup
University of Defence
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ondřej Soukup.
MedChemComm | 2015
Galina Karabanovich; Jaroslav Roh; Ondřej Soukup; Ivona Pávková; Markéta Pasdiorová; Vojtěch Tambor; Jiřina Stolaříková; Marcela Vejsova; Kateřina Vávrová; Věra Klimešová; Alexandr Hrabálek
Tetrazole derivatives containing nitro substituents have been identified as promising antitubercular agents. In this study, the antitubercular potency, selectivity and toxicity of tetrazole 1,5- and 2,5-regioisomers were examined. We prepared a series of 1- and 2-alkyl-5-benzylsulfanyl-2H-tetrazoles and their selenium analogs with various nitro group substitutions. These 1,5- and 2,5-regioisomers were isolated and unambiguously identified using 1H and/or 13C NMR. Among the prepared compounds, 1- and 2-alkyl-5-[(3,5-dinitrobenzyl)sulfanyl]-2H-tetrazole derivatives and their selenium bioisosteres showed the highest antimycobacterial activity, with minimal inhibitory concentration (MIC) values of approximately 1 μM (0.37–0.46 μg mL−1) against Mycobacterium tuberculosis CNCTC My 331/88. The 2-alkyl regioisomers exhibited consistently higher antimycobacterial activity and lower in vitro toxicity against a mammalian cell line compared to the 1-alkyl isomers. The antimycobacterial activity of the 2-alkyl regioisomers was less influenced by the type of alkyl substituent in contrast to 1-alkyl isomers. Furthermore, the 3,5-dinitrobenzyl moiety per se is not the carrier of mutagenicity. These findings encourage further optimization of the 2-alkyl chain to improve the pharmacokinetic properties and toxicity of 2-alkyl-5-[(3,5-dinitrobenzyl)sulfanyl]-2H-tetrazole lead compounds.
Military Medical Science Letters | 2015
Namrata Singh; Ondřej Soukup; Rafael Doležal; Zdeněk Fišar; Bhanushree Gupta; Kallol K. Ghosh; Kamil Kuca
1 Department of Psychiatry, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, KeKarlovu 11, 120 00 Prague 2, Czech Republic 2 Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic 3 Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defense, Trebesska 1575, Kralove, Czech Republic 4 School of Studies in Chemistry, Pt. Ravishankar Shukla University, Raipur (C.G.), 492010, India 5 Department of Chemistry, Indian Institute of Technology Kanpur, Kanpur (U.P.), 208016 India
Analytical Letters | 2018
Rafael Doležal; Natálie Karásková; Karel Musil; Martin Novák; Nadezhda V. Maltsevskaya; Dávid Maliňák; Karel Kolář; Ondřej Soukup; Kamil Kuca; Jana Žďárová Karasová
ABSTRACT The biological activity of drugs on organisms is associated with the pharmacokinetic properties, such as the ability to penetrate through environments of varying polarity such as cellular organelles. In this area, particular attention is turned to the physicochemical properties that determine the potential of drugs to pass across the blood–brain barrier and thus to act on the central nervous system. In this study, special effort has been devoted to the simulation of passive diffusion of seven drugs (propranolol, ibuprofen, atenolol, promazine, chlorpromazine, imipramine, and desipramine) through the blood–brain barrier by high-performance liquid chromatography (HPLC) using a column with an immobilized artificial membrane. Gradient reverse elution was used to develop a linear correlation model for the capacity factors kIAM and the in vivo logarithmic values of brain-to-blood drug concentration ratios (log BB) with R of 0.9851. Eleven additional pharmaceuticals were determined by the same method to predict their potential to penetrate the blood–brain barrier. The reported analytical method represents an alternative tool for rapid and noninvasive assessment of the absorption properties of chemicals, especially for the development of novel drugs. The retention of the studied compounds on the immobilized artificial membrane column was also compared with three other C18-based stationary phases. Herein, the results of the HPLC determination of drugs using an immobilized artificial membrane are briefly discussed with respect to a general application of the method for evaluating a broader spectrum of pharmaceutical compounds.
European Journal of Medicinal Chemistry | 2016
Laís Flávia Nunes Lemes; Giselle de Andrade Ramos; Andressa Souza de Oliveira; Fernanda Silva; Gina de Castro Couto; Marina da Silva Boni; Marcos Jorge R. Guimarães; Isis Nem de Oliveira Souza; Manuela Bartolini; Vincenza Andrisano; Patrícia Coelho do Nascimento Nogueira; Edilberto R. Silveira; Guilherme D. Brand; Ondřej Soukup; Jan Korábečný; Nelilma C. Romeiro; Newton G. Castro; Maria Laura Bolognesi; Luiz Antonio Soares Romeiro
European Journal of Medicinal Chemistry | 2017
Jakub Jeřábek; Elisa Uliassi; Laura Guidotti; Jan Korábečný; Ondřej Soukup; Vendula Sepsova; Martina Hrabinova; Kamil Kuca; Manuela Bartolini; Luis Emiliano Peña-Altamira; Sabrina Petralla; Barbara Monti; Marinella Roberti; Maria Laura Bolognesi
European Journal of Medicinal Chemistry | 2017
Jan Němeček; Pavel Sychra; Miloslav Macháček; Markéta Benková; Galina Karabanovich; Klára Konečná; Věra Kavková; Jiřina Stolaříková; Alexandr Hrabálek; Kateřina Vávrová; Ondřej Soukup; Jaroslav Roh; Věra Klimešová
Journal of Applied Biomedicine | 2010
Ondřej Soukup; Ondřej Holas; Jiří Binder; Kumar Killy; Gunnar Tobin; Daniel Jun; Josef Fusek; Kamil Kuca
Molecular BioSystems | 2016
Jana Janockova; E. Zilecka; Jana Kasparkova; Viktor Brabec; Ondřej Soukup; Kamil Kuca; Maria Kozurkova
Military Medical Science Letters | 2012
Jan Marek; Petr Stodůlka; Ondřej Soukup; Kamil Musilek; Jiří Cabal; Kamil Kuca
MMSL | 2018
Yevgen Karpichev; Illia V. Kapitanov; Nicholas Gathergood; Ondřej Soukup; Vendula Hepnarova; Daniel Jun; Kamil Kuca